Nimenrix Meningococcal ACWY Vaccine - Tetanus Toxoid Conjugate
Nimenrix Meningococcal ACWY Vaccine - Tetanus Toxoid Conjugate
Product Description:
Nimenrix is a conjugate vaccine designed for active immunization against invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, W-135, and Y. The vaccine is formulated by conjugating the polysaccharides from these four serogroups to a carrier protein, tetanus toxoid, enhancing the immune response to the polysaccharides. Nimenrix is indicated for use in individuals from 6 weeks of age and older, providing broad protection against these significant causes of bacterial meningitis and septicemia.
Technical Specifications:
- Vaccine Type: Conjugate vaccine
- Serogroups: A, C, W-135, and Y
- Carrier Protein: Tetanus toxoid
- Age Indication: Suitable for individuals from 6 weeks of age and older
- Administration: Intramuscular injection
- Storage: Store refrigerated between 2°C and 8°C (35°F and 46°F)
- Shelf Life: Check the packaging for the expiration date
- Presentation: Single-dose vial or pre-filled syringe
Common Applications/User Groups:
- Routine childhood immunization programs
- Travelers to areas with high incidence or outbreaks of meningococcal disease
- Adolescents and young adults living in close quarters, such as dormitories
- Military personnel
- Individuals with compromised immune systems or asplenia
- Laboratory personnel handling Neisseria meningitidis specimens
Supplier Overview:
GlaxoSmithKline (GSK) is a global healthcare company with a long-standing reputation in the development and manufacturing of vaccines. With a commitment to improving the quality of human life by enabling people to do more, feel better, and live longer, GSK has established itself as an authority in the vaccine space. Their extensive research and development efforts, coupled with rigorous safety and efficacy testing, ensure that their products, such as Nimenrix, meet the highest standards of quality and protection. GSK's expertise in the field of infectious diseases and their global presence make them a trusted supplier of vaccines to combat serious illnesses like meningococcal disease.
Product Information
Product Information
Shipping & Returns
Shipping & Returns
Description
Nimenrix Meningococcal ACWY Vaccine - Tetanus Toxoid Conjugate
Product Description:
Nimenrix is a conjugate vaccine designed for active immunization against invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, W-135, and Y. The vaccine is formulated by conjugating the polysaccharides from these four serogroups to a carrier protein, tetanus toxoid, enhancing the immune response to the polysaccharides. Nimenrix is indicated for use in individuals from 6 weeks of age and older, providing broad protection against these significant causes of bacterial meningitis and septicemia.
Technical Specifications:
- Vaccine Type: Conjugate vaccine
- Serogroups: A, C, W-135, and Y
- Carrier Protein: Tetanus toxoid
- Age Indication: Suitable for individuals from 6 weeks of age and older
- Administration: Intramuscular injection
- Storage: Store refrigerated between 2°C and 8°C (35°F and 46°F)
- Shelf Life: Check the packaging for the expiration date
- Presentation: Single-dose vial or pre-filled syringe
Common Applications/User Groups:
- Routine childhood immunization programs
- Travelers to areas with high incidence or outbreaks of meningococcal disease
- Adolescents and young adults living in close quarters, such as dormitories
- Military personnel
- Individuals with compromised immune systems or asplenia
- Laboratory personnel handling Neisseria meningitidis specimens
Supplier Overview:
GlaxoSmithKline (GSK) is a global healthcare company with a long-standing reputation in the development and manufacturing of vaccines. With a commitment to improving the quality of human life by enabling people to do more, feel better, and live longer, GSK has established itself as an authority in the vaccine space. Their extensive research and development efforts, coupled with rigorous safety and efficacy testing, ensure that their products, such as Nimenrix, meet the highest standards of quality and protection. GSK's expertise in the field of infectious diseases and their global presence make them a trusted supplier of vaccines to combat serious illnesses like meningococcal disease.
